Skip to main content
Equibles

ALC · Alcon Inc

Track ALC — free

Use ALC with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$70.50 -1.58 (-2.19%) At close · Sep 4
Rebalance outlook locked
Market Cap
$34.27B
Shares
483.40M

ALC metrics

78 of 114 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$70.50
Market cap
$34.27B

Price action

19 metrics
Price change (1W)
-2.1%
Price change (30D)
-1.8%
Price change (3M)
+5.5%
Price change (6M)
-13.3%
Price change (YTD)
-10.5%
Price change (1Y)
-10.7%
Trailing year
Price change (5Y)
-16.6%
52-week high
$87.18
52-week low
$62.02
Change from 52-week high
-19.1%
Change from 52-week low
+13.7%
Annualized volatility
27.7%
Beta
0.5
RSI (14D)
43.4
Price vs SMA 50
+0.2%
Price vs SMA 200
-5.3%
Avg volume (3M)
1.88M
Relative volume
0.7
Average dollar volume
$130.20M

Company

3 metrics
Sector
Healthcare
Industry
Medical Instruments & Supplies
Shares outstanding
483.40M

Valuation

12 metrics
P / E (TTM)
31.9
Trailing earnings · reciprocal yield 3.1%
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
3.4×
reciprocal yield 29.3%
P / book
1.6
reciprocal yield 64.3%
FCF yield
4.7%
TTM · current market cap
Buyback yield
0.3%
P / FCF
21.2
reciprocal yield 4.7%
P / operating cash flow
16.4
reciprocal yield 6.1%
Earnings yield
3.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
0.5%
Trailing 12 months
Payout ratio
15.5%
Shareholder yield
0.8%
Dividend / share (TTM)
$0.36
Dividend growth YoY
+8.2%
Dividend growth streak
4
Last ex-dividend
2026-05-05

Earnings calendar

2 metrics
Next earnings
2026-11-11
Last earnings
2026-08-11

Profitability

9 metrics
Gross margin
55.1%
Operating margin
14.4%
Trailing 12 months
Net margin
10.7%
Gross profit (TTM)
$5.53B
Operating profit (TTM)
$1.44B
Net income (TTM)
$1.07B
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
16.1%
Effective tax rate
14.4%

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$45.20

Growth

11 metrics
Revenue growth YoY
+4.0%
Year over year
Net income growth YoY
-21.1%
Revenue (TTM)
$10.03B
Trailing 12 months
EPS growth YoY
-22.2%
Shares change YoY
+0.7%
Year over year · more shares
Revenue CAGR (3Y)
+6.1%
Revenue CAGR (5Y)
+8.8%
EPS CAGR (3Y)
+42.8%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
+43.8%
FCF CAGR (5Y)
+38.1%

Quality

14 metrics
Return on equity
4.9%
Return on assets
3.4%
Debt / equity
—
Current ratio
2.1
EBITDA (TTM)
—
Free cash flow (TTM)
$1.62B
Quick ratio
1.3
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$1.53B
Total assets
$31.55B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
$2.10B
Capital expenditures (TTM)
$477.00M
R&D (TTM)
$924.00M
SG&A (TTM)
—
Stock compensation (TTM)
$78.00M
R&D / revenue
9.2%
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
632
13F filer change QoQ
-27
Institutional ownership
52.9%

Short interest

3 metrics
Short interest
2.5%
Latest settlement · 5.4 days to cover
Days to cover
5.4d
Short-squeeze score
63 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1167379 CUSIP H01301128 13F (30d) 348 filings 339 filers Visit website Investor relations